22 May 2013
Keywords: AstraZeneca, Aptium Oncology, Assets sale, Oncology management services, USA
Article | 09 July 2012
Anglo-Swedish drug major AstraZeneca (LSE: AZN) says that it has completed the previously indicated sale of the assets of its ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
9 July 2012
© 2013 thepharmaletter.com